CALL/FRESENIUS MEDICAL CARE/60/0.1/20.12.24 Share Price

Warrant

DE000GZ86QS6

Real-time BOERSE MUENCHEN 11:25:12 13/06/2024 BST
0.024 EUR -14.29% Intraday chart for CALL/FRESENIUS MEDICAL CARE/60/0.1/20.12.24
Current month-3.45%
1 month-26.32%
Date Price Change
13/06/24 0.024 -14.29%
12/06/24 0.028 -3.45%
11/06/24 0.029 -9.37%
10/06/24 0.032 0.00%
07/06/24 0.032 +3.23%

Real-time BOERSE MUENCHEN

Last update June 13, 2024 at 11:25 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer Goldman Sachs
WKN GZ86QS
ISINDE000GZ86QS6
Date issued 03/02/2023
Strike 60
Maturity 20/12/2024 (191 Days)
Parity 10 : 1
Emission price 0.13
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.401
Lowest since issue 0.024
Spread 0.01
Spread %30.30%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
40.05 EUR
Average target price
39.97 EUR
Spread / Average Target
-0.19%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW